YouTube will now let you use AI to build custom feeds of videos, in a move similar to competitors like Reddit, Bluesky, and TweetDeck X. Announced on Wednesday, Google described the personalised feed ...

Australia's water supplies are evaporating. According to researchers at Deakin University, the country's water infrastructure loses nearly 370 billion gallons every year due to evaporation, about ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. CBC News has traced ...

Minecraft Create Aeronautics is a brand new mod that brings loads of new mechanics to the already-popular mod, Create. This particular mod was in development for nearly four years, with its pre-alpha ...

YouTube is now letting users create an AI avatar that looks and sounds like them for use in Shorts. This feature was teased earlier this year. The creation process is available in the main YouTube app ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

YouTube Music has released an AI playlist maker for Premium members on iOS and Android. Users can quickly make custom mixes by typing or speaking about certain moods or “vibes.” This move comes after ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...